Screener
Annexon ANNX R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Annexon in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Annexon’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211931
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $35,786 | $48,179 |
| General and administrative | 10,267 | 9,226 |
| Total operating expenses | 46,053 | 57,405 |
| Loss from operations | (46,053) | (57,405) |
| Interest and other income, net | 1,911 | 3,049 |
| Net loss | $(44,142) | $(54,356) |
| Net loss per share, basic and diluted | $(0.23) | $(0.37) |
Cover / Front Matter
FAQ
- What is Annexon's R&D?
- Annexon (ANNX) reported R&D of $35.79M in Q1 2026.
- How has Annexon's R&D changed year-over-year?
- Annexon's R&D decreased by 25.7% year-over-year, from $48.18M to $35.79M.
- What is the long-term trend for Annexon's R&D?
- Over 4 years (2021 to 2025), Annexon's R&D has grown at a 16.6% compound annual growth rate (CAGR), from $100.07M to $184.7M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Annexon's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude